Brief: Zivo Bioscience And Tianjin Norland Biotech Execute LOI To Produce Zivo Algae Strain In China
01/02/2018 12:52
Feb 1 (Reuters) - Zivo Bioscience Inc ZIVO.PK :
* ZIVO BIOSCIENCE AND TIANJIN NORLAND BIOTECH EXECUTE LETTER
OF
INTENT TO PRODUCE ZIVO ALGAE STRAIN IN CHINA FOR INTERNATIONAL
AND DOMESTIC MARKETS
* ZIVO BIOSCIENCE INC - EXECUTED LETTER OF INTENT TO
PRODUCE ITS
PROPRIETARY ALGAE STRAIN AT TIANJIN NORLAND BIOTECH FACILITIES
IN CHINA
* ZIVO BIOSCIENCE INC - ANTICIPATES THAT IT WILL ENTER INTO
DEFINITIVE, BINDING PRODUCTION AGREEMENT WITH TIANJIN NORLAND
BIOTECH LATER IN 2018
Source text for Eikon: ID:nGNXOMVHNa
Further company coverage: ZIVO.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens